HCV E1E2 vaccine compositions

Details for Australian Patent Application No. 2002322358 (hide)

Owner Novartis Vaccines and Diagnostics, Inc.

Inventors Coates, Stephen, R.; Houghton, Michael; Fong, Yiu-Lian; O'Hagan, Derek

Agent FB Rice

Pub. Number AU-B-2002322358

PCT Number PCT/US02/20676

PCT Pub. Number WO2003/002065

Priority 60/302,227 29.06.01 US

Filing date 28 June 2002

Wipo publication date 3 March 2003

Acceptance publication date 18 June 2009

International Classifications

A61K 39/29 (2006.01) Medicinal preparations containing antigens or antibodies - Hepatitis virus

A61K 9/107 (2006.01) Medicinal preparations characterised by special physical form - Emulsions

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61K 47/06 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Organic compounds

A61K 47/22 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Heterocyclic compounds

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

C07K 14/18 (2006.01) Peptides having more than 20 amino acids

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 60/302,227 29.06.01 US

15 May 2003 Application Open to Public Inspection

  Published as AU-B-2002322358

20 January 2005 Amendment Made

  The nature of the amendment is: Add co-inventor to Fong, Yiu-Lian 2003

30 October 2008 Alteration of Name

  The name of the applicant has been altered to Novartis Vaccines and Diagnostics, Inc. Amendments

18 June 2009 Application Accepted

  Published as AU-B-2002322358

15 October 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002322359-APPARATUS, METHOD AND SYSTEM WITH A GRAPHICS-RENDERING ENGINE HAVING A GRAPHICS CONTEXT MANAGER

2002322357-METHOD AND APPARATUS FOR COMPUTER MODELING OF AN ADAPTIVE IMMUNE RESPONSE